Advisory Board member and columnist David Schmiege interviews Stuart A. Harlin, MD, for this issue. Dr. Harlin is an associate professor and the director of outpatient vascular operations within the Department of Cardiothoracic and Vascular Surgery at McGovern Medical School…
Penumbra Inc. has announced its next phase for vascular franchise growth with U.S. commercial availability of the Indigo System Lightning 12 and the appointments of Corey L. Teigen, MD, to chief scientific officer; and James F. Benenati, MD, FSIR, to…
Boston Scientific has been granted a new technology add-on payment (NTPA) for its Eluvia drug-eluting vascular stent system from the Centers for Medicare & Medicaid Services. Under the Inpatient Prospective Payment System (IPPS), CMS pays for a patient’s inpatient hospital…
PHILIPS TO ACQUIRE INTACT VASCULAR Royal Philips has signed an agreement to acquire Intact Vascular Inc., a U.S.-based developer of medical devices for minimally invasive peripheral vascular procedures for $275 million upfront deferred payments when the transaction is completed.…
By Larry Storer I generally do not write editor columns, but the staff decided I really needed to write this one because of my perspective as a patient during the COVID-19 pandemic. My medical journey has lasted just longer than…
An interview by David Schmiege, president and CEO of Vein Specialists of America with Jeffrey H. Miller, MD Dr. Miller Board-certified in Interventional Radiology and Venous and Lymphatic Medicine Diplomat of the National Board of Medical…
By Robert Jennejohn Dr. Michael Y. Shao, MD is a board-certified vascular surgeon with the Swedish Medical Group. He attended the Mount Sinai School of Medicine. He has more than 17 years of experience and is currently affiliated with…